Decreased docosahexaenoic acid (DHA) and brain-derived neurotrophic factor (BDNF) have been implicated in bipolar disorder. It also has been reported that dietary deprivation of n-3 polyunsaturated fatty acids (PUFAs) for 15 weeks in rats, increased their depression and aggression scores. Here, we show that n-3 PUFA deprivation for 15 weeks decreased the frontal cortex DHA level and reduced frontal cortex BDNF expression, cAMP response element binding protein (CREB) transcription factor activity and p38 mitogen-activated protein kinase (MAPK) activity. Activities of other CREB activating protein kinases were not significantly changed. The addition of DHA to rat primary cortical astrocytes in vitro, induced BDNF protein expression and this was blocked by a p38 MAPK inhibitor. DHA's ability to regulate BDNF via a p38 MAPK-dependent mechanism may contribute to its therapeutic efficacy in brain diseases having disordered cell survival and neuroplasticity.
Introduction
The mammalian brain is rich in docosahexaenoic acid (DHA, 22:6n-3), 1 which regulates brain structure, signaling and plasticity. [2] [3] [4] [5] [6] DHA is obtained directly from the diet or is synthesized in the liver from its dietary precursors a-linolenic acid (a-LNA, 18:3n-3) or eicosapentaenoic acid (EPA, 20:5n-3), neither of which can be synthesized de novo in mammalian tissue. 7 Both of these fatty acids are present at low concentrations in brain. 7, 8 Epidemiological observations point to a decreased dietary n-3 polyunsaturated fatty acid (PUFA) intake being associated with an increased prevalence of bipolar disorder. 9 Blood DHA levels 10, 11 and postmortem prefrontal cortex DHA levels are 16.5% lower in bipolar patients compared to normal controls. 12 Two randomized clinical trials have shown n-3 PUFA supplementation to be beneficial in treating bipolar symptoms. 13, 14 Consistent with these clinical observations, 15 weeks of dietary n-3 PUFA deprivation in rats increased their scores on tests of aggression and depression. 15 The transcription factor, cyclic AMP-dependent response element binding protein (CREB), regulates the expression of many genes, including brainderived neurotrophic factor (BDNF), which increases neuroplasticity and cell survival. [16] [17] [18] [19] [20] [21] [22] [23] Protein kinases that phosphorylate CREB induce binding of CREB to the CRE consensus sequence in chromatin. These kinases include protein kinase A (PKA), [24] [25] [26] protein kinase C (PKC), 27 p38 and p44 mitogen-activated protein kinases (MAPK), 28, 29 and Ca 2 þ -calmodulin kinase (CaMK) IV. 30 Of relevance to bipolar disorder, BDNF levels are decreased in the serum, 31 and BDNF and phosphorylated CREB levels are decreased in the brain of bipolar patients compared to controls. 32, 33 A Val66Met polymorphism in the BDNF gene confers susceptibility to bipolar disorder in humans [34] [35] [36] and a BDNF-linked complex polymorphic region, which has lower transcriptional activity than other alleles in rat primary cultured neurons, also confers susceptibility to bipolar disorder in humans. 37 As well, drugs used to treat bipolar disorder (lithium and valproate) increase BDNF levels in rat brain. 38, 39 Decreased BDNF levels are thought to contribute to bipolar disorder symptoms [40] [41] [42] while dietary n-3 PUFA supplementation improves symptoms, 13, 14 and normalizes BDNF levels after traumatic brain injury in rats. 43 As a result of these observations, we hypothesized that dietary n-3 PUFA deprivation in rats would decrease frontal cortex BDNF levels and that this decrease would be related to changes in activity of CREB and of kinases that phosphorylate CREB. We made our measurements in the frontal cortex, because functional imaging has shown structural abnormalities in the prefrontal cortex in bipolar disorder, which could be related to disturbed mood and emotional processing. 44 Additionally, post-mortem investigations have shown decreased gray matter volume, lower DHA concentrations, and reduced neuronal and glial densities in the frontal cortex of bipolar disorder patients. 12, [45] [46] [47] Upon finding that BDNF, phosphorylated CREB and p38 MAPK were decreased in the rat frontal cortex after 15 weeks of dietary n-3 PUFA deprivation, we used rat primary cortical astrocytes to show that DHA induction of BDNF was blocked by a p38 MAPK inhibitor.
Materials and methods
This study was carried out according to the National Institutes of Health Guidelines for Animal Care and Use (Publication No. , and was approved by the National Institute of Child Health and Human Development Animal Care and Use Committee. Male Long-Evans rat pups (18-day-old) and their nursing surrogate mothers were purchased from Charles River Laboratories (Portage, MI, USA). The pups were not littermates. The animals were housed in a facility with regulated temperature (241C) and humidity (40-70%), under a 12 h light/dark cycle. They were allowed to nurse until 21 days old, then removed from their mothers, mixed without identification, and assigned randomly to an n-3 PUFA adequate (n = 15) or n-3 PUFA deprived diet group (n = 15). The diets were purchased from Dyets Inc. (Bethlehem, PA, USA), and their composition are reported elsewhere. 48, 49 They were based on the AIN-93 diet and only differed with regard to fat composition. The n-3 adequate diet contained 6.0, 3.2 and 0.8 (g/100 g diet) hydrogenated coconut oil, safflower oil and flaxseed oil, respectively, while the n-3 PUFA deficient diet contained 6.6, 3.4 and 0 (g/100 g diet) hydrogenated coconut oil, safflower oil and flaxseed oil, respectively. The n-3 PUFA adequate diet contained 63.9, 5.3, 26.4 and 4.4% of total fat as saturated fatty acids, monounsaturated fatty acids, linoleic acid (18:2n-6) and a-linolenic acid (18:3n-3), respectively, compared to 69.5, 4.1, 26.4 and 0.04%, respectively, for the n-3 PUFA-deficient diet. Food and water were provided ad libitum, and food in the cage was replaced with fresh food every 2-3 days. After 15 weeks on a given diet, a rat was anaesthetized by CO 2 inhalation and decapitated. The brain was rapidly excised and the frontal cortex was dissected, frozen in 2-methyl butane at À501C, and stored at À801C until use.
Rat primary cortical astrocytes
Rat primary cortical astrocytes were purchased from Cambrex Corporation, Walkersville, MD, USA. Cells were grown according to the manufacturer's instructions. After the cells were confluent, they were seeded on a 6-well plate at a density of 5 Â 10 4 . Supplementation of 1.5 mM DHA to primary hippocampal neurons promotes neurite growth, 50 a concentration that is close to the unesterified DHA concentration of the rat brain (1.370.7 nmol/g, mean7s.d.). 51 These cells were treated with DHA (1.5 mM) (Sigma, St Louis, MO, USA) or DHA and a 20 mM p38 MAPK inhibitor (SB202190, Upstate Biotech, NY, USA) or 20 mM SB202190 without additional DHA. All cells were grown in an ABGM medium containing a-tocopherol (40 mM) and BSA (0.01%). Cells without DHA were treated with same amount of a-tocopherol (40 mM) and BSA (0.01%).
Immunoflorescence Cells were fixed with 5% paraformaldehyde for 2 min and incubated with primary glial fibrillary acidic protein (GFAP, Sigma) (1:100) overnight, followed by incubation with a Texas-red labeled secondary antibody (1:100) for 1 h at 41C. Cells were also stained for 4 0 -6-diamidino-2-phenylindole (DAPI, Sigma) (1:100) and incubated for 10 min. Cells were then visualized using florescence microscopy.
DHA quantification
Total lipids were extracted from the frontal cortex by the method of Folch. 52 A known amount of 1,2-diheptadecanoyl-sn-glycero-3-phosphocholine (Sigma) was added to a portion of the tissue as an internal standard before extraction. Fatty acid methyl esters were formed by heating a portion of the total lipid extracts in 1% H 2 SO 4 in methanol at 701C for 3 h. 53 The methyl esters were extracted and separated on a 30mÂ 0.25 mm i.d. capillary column (SP-2330, Supelco; Bellefonte, PA, USA), using gas chromatography with a flame ionization detector (Model 6890N, Agilent Technologies; Palo Alto, CA, USA). Runs were initiated at 801C with a temperature gradient to 1601C (101C/min) and 2301C (31C/min) in 31 min, and held at 2301C for 10 min. Peaks were identified by retention times of fatty acid methyl ester standards (Nu-Chek-Prep, Elysian, MN, USA). Brain DHA concentrations (mmol/g brain wet weight) were calculated by proportional comparison of their gas chromatography peak areas to that of the heptadecaenoic acid (17:0) internal standard. 54 Preparation of cytosolic and nuclear extracts Cytoplasmic and nuclear extracts were prepared from frontal cortex as described. 55 Briefly, the cortex was homogenized in 10 mM HEPES, pH 7.9, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM DTT, 10 mM KCl, buffer with a protease inhibitor cocktail (Roche, Indianapolis, IN, USA) using a Teflon-glass homogenizer. After adding 0.5% NP-40, five additional strokes of homogenization were performed. The suspension was incubated for 10 min on ice, and then centrifuged in a micro centrifuge at 13 000 g for 1 min at 41C. The supernatant contained mostly cytoplasmic constituents. To the nuclear pellet, solution B (20 mM HEPES, pH 7.9, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 0.4 M NaCl) and a protease inhibitor cocktail (Roche) were added. Tubes were mixed and placed on a small rotatory shaker for n-3 PUFA deprivation decreases BDNF levels JS Rao et al 30 min. Finally, the mixture was centrifuged at 13 000 g for 3 min at 41C. The supernatant containing the proteins from the nuclear extracts was transferred to a fresh tube.
Astroglial cells were sonicated in a HEPES (10 mM) buffer pH 7.9, containing 0.1 mM EDTA, 0.1 mM EGTA, 1 mM DTT, 10 mM KCl, buffer with a protease inhibitor cocktail (Roche). Cell extracts were obtained after centrifugation at 17 000 g for 2 min. Protein concentrations of cytoplasmic and nuclear brain extracts and astrocytic extracts were determined using Bio-Rad protein Reagent (Bio-Rad, Hercules, CA, USA).
BDNF protein levels BDNF levels were measured in brain cytosolic and astroglial cellular extracts using an ELISA kit according to the manufacturer's instructions (Chemicon International, Temecula, CA, USA). Values are expressed in pmol/mg protein.
Total RNA isolation and real-time RT-PCR Total RNA was isolated from frontal cortex using an RNeasy mini kit for brain and lipid tissue (Qiagen, Valencia, CA, USA). cDNA was prepared from total RNA using a high-capacity cDNA Archive kit (Applied Biosystems, Foster City, CA, USA). BDNF mRNA levels were measured by real-time quantitative RT-PCR, using an ABI PRISM 7000 sequence detection system (Applied Biosystems). Specific primers and probes for BDNF (Assays-on-Demand, Applied Biosystems) consisted of a 20 Â mix of unlabeled PCR primers and Taqman minor groove binder (MGB) probe (FAM dye-labeled). The fold change in gene expression was determined by using the DDC T method.
56 Data were expressed as the level of the target gene (BDNF) in the n-PUFA-deprived animals normalized to the endogenous control (b-globulin) and relative to the n-3 PUFA-adequate animals (calibrator), as previously described. 57 All experiments were carried out twice in triplicate with six independent samples.
CREB protein DNA-binding activity An electrophoretic mobility shift assay was performed on the nuclear extracts. Gelshift assays were performed with 20 mg of nuclear protein extract, incubated with a nonradioactive (10 ng) biotinlabeled DNA oligo CREB consensus sequence (5 0 -AGAGATTGCCTGACGTCAGAGACGTAG-3 0 ) (Panomics, Redwood City, CA, USA) in gelshift buffer (10 mM Tris-HCl, pH 7.5, 50 mM NaCl, 1 mM MgCl 2 , 0.5 mM EDTA, 0.5 mM DTT, 4% glycerol and 50 mg/ml poly dI: dC) for 30 min on ice. The DNA-protein complex was separated on 5% TBE gel and electrophoretically transferred to a nylon membrane. Biotinlabeled oligonucleotide complexes were visualized using a streptavidin-HRP conjugate coupled with chemiluminescence on X-ray film (XAR-5, Kodak, Rochester, NY, USA). The specificity of the transcription factor was determined by using 100 times excess unlabeled probe with a fixed amount of biotin labeled DNA oligo consensus (10 ng) and nuclear extracts (20 mg protein). For the super shift assay, nuclear extracts (20 mg proteins) were preincubated with antibody (1 mg) for CREB (Upstate, Lake Placid, NY, USA) for 60 min at 41C. Then the gelshift assay was performed as described above. All gelshift assay experiments were carried out twice with 10 animals in each group. ODs of gelshift bands were quantified using Alpha Innotech software (Alpha Innotech, San Leandro, CA, USA). Values were expressed as percent of n-3 PUFA-adequate rat values.
Western blot analysis Cellular (60 mg protein) and nuclear extracts (60 mg protein) were separated on 10% SDS-polyacrylamide gels (PAGE) (Bio-Rad). Following SDS-PAGE, proteins were electrophoretically transferred to a nitrocellulose membrane. Blots were incubated overnight with 1:1000 specific primary antibodies for CREB and phosphorylated CREB (Cell Signaling), followed by HRP-conjugated secondary antibodies (Bio-Rad). Blots were visualized using a chemiluminescence reaction (Amersham, Piscataway, NJ, USA) on X-ray film (XAR-5, Kodak). Optical densities of immunoblot bands were measured using Alpha Innotech Software (Alpha Innotech). All experiments were carried out twice with 10 independent samples. ODs were normalized to b-actin (Sigma) to correct for unequal loading. Values were expressed as a percent of n-3 PUFA-adequate rat values.
PKC and PKA activities Basal PKC activity was measured in brain cytoplasmic extracts (10 mg protein) using a nonradioactive PKC kinase assay kit (Stressgen Bioreagents, Victoria, BC, Canada). 58 Basal PKA activity was determined using a nonradioactive PKA assay kit (Stressgen Bioreagents). This is an enzyme-linked immunoabsorbent assay that uses a specific synthetic peptide as a substrate for PKA and a polyclonal antibody that recognizes the phosphorylated form of the substrate. Briefly, total brain cytoplasmic or astrocyte extract protein (15 mg protien) was incubated with immobilized substrate. The reaction was initiated by adding ATP. The kinase reaction was terminated after 60 min of incubation, and then a phosphospecific substrate antibody was added. A peroxidase-conjugated secondary antibody subsequently was bound to the phospho-specific antibody. The assay was developed by adding the tetramethylbenzidine substrate (TMB) and color intensity was measured at 450 nm. The intensity of color development is proportional to phosphotransferase activity. An individual sample reading was corrected by subtracting the corresponding blank reading (without cytoplasmic extract). Ten independent samples were used in each group and each sample was assayed in triplicate and experiments carried out twice. All the values within the intra and inter assay coefficients of variation of < 10% n-3 PUFA deprivation decreases BDNF levels JS Rao et al were taken for calculating PKA activities. Values were expressed as relative PKA activity.
p38 and p44 MAPK activities p38 a and p44 MAPK assays were carried out in the cytosolic fraction using a MAPK immunoprecipitation assay kit (Upstate) and a p38 a assay kit (Calbiochem International, Temecula, CA, USA). Briefly, brain cytoplasmic (200 mg) or astrocytic extracts (100 mg) were incubated for 3 h with anti p44 MAPK or anti-phosphorylated p38 MAPK antibody in presence of agarose beads A/G at 41C. Immunoprecipitated complexes were washed three times with immunoprecipitation buffer (50 mM Tris pH 7.5, 1 mM EDTA, 1 mM EGTA, 0.1% 2 mercaptoethanol, 1% triton-X, 0.5 mM Na3VO4, 5 mM sodium pyrophosphate, 10 mM sodium b-glycero phosphate and protease inhibitors). p44 MAPK (5 ml) or 50 ml of p38 MAPK immunoprecipitated complexes was incubated using an assay kit providing myelin basic protein (MBP) or GST ATF-2 as substrates at 301C according to the manufacturer's protocol. After incubation, 2.5 ml of supernatant of p44 MAPK or 50 ml p38 MAPK were eluted and subjected to SDS-PAGE for immunoblot analysis. The phosphorylated MBP or phosphorylated ATF-2 complexes were detected using polyclonal antiphosphorylated MBP (15 mg/ml) or antiphosphorylated ATF-2 (1:5000) followed by HRP-conjugated secondary antibody (goat anti-mouse antibody). Blots were visualized using a chemiluminescence reaction. ODs were measured and values were expressed as percent of n-3 PUFA-adequate rat values.
Phosphorylated p38, p42 and p44 MAPK Phosphorylated p38, p42, and p44 MAPK levels were measured in nuclear extracts. Nuclear extract proteins were separated by SDS gel electrophoresis as described for Western blot analysis. Nuclear extracts protein blots were incubated overnight with antiphosphorylated p42 or p44 MAPK (Santa Cruz) (1:200 dilution) or antiphosphorylated p38 MAPK antibody (R&D Systems, 1:200 dilution), followed by HRPconjugated secondary antibodies (Bio-Rad). Blots were visualized using a chemiluminescence reaction (Amersham) on X-ray film (XAR-5, Kodak). ODs of immunoblot bands were measured using Alpha Innotech Software (Alpha Innotech). All experiments were carried out twice with 10 independent samples. ODs were normalized to b-actin (Sigma) to correct for unequal loading. Values were expressed as a percent of n-3 PUFA-adequate rat values.
CaMK IV activity
CaM kinase IV activity was measured in cytosolic fractions using a CaMK IV Fluorescein Green assay kit (Upstate Biotech). The CaMK IV enzyme was immunoprecipitated from cytosolic using an anti CaMK antibody (Santa Cruz) as described in the MAPK activity method. The immunoprecipitated CaMK was used for determining CaMK IV activity according to the manufacturer's protocol. CaMK IV activity was expressed as fluorescence polarization.
Statistical analysis
Data are expressed as means7s.e.m. Statistical significance was calculated using a two-tailed, unpaired t-test or a one-way ANOVA with Bonferroni's multiple comparison test. Statistical significance was set at P < 0.05.
Results
Decreased DHA concentration in frontal cortex of n-3 PUFA-deprived rats Fifteen weeks of n-3 PUFA deprivation significantly decreased (27%) the DHA concentration (1270.4 mmol/g brain) in the frontal cortex compared to the concentration in n-3 PUFA adequate rats (1970.5 mmol/g brain) (P = 0.0001).
Decreased BDNF protein and mRNA levels in n-3 PUFA-deprived rats N-3 PUFA deprivation significantly decreased frontal cortex BDNF protein by 30% (n = 10, P = 0.040) and BDNF mRNA by 63% (n = 6, P = 0.040) compared to levels in n-3 PUFA-adequate rats (Figures 1a and b) .
Decreased CREB protein DNA-binding activity in n-3 PUFA-deprived rats The addition of CREB primary antibody to brain extracts generated the super-shift of the CREB protein band, indicating the presence of CREB protein ( Figure  2a ). As shown in Figure 2b , in the presence of excess (100 times) unlabeled specific CREB oligonucleotides, the binding of labeled oligonucleotides was blocked, indicating specificity of DNA-binding activities. Fifteen weeks of n-3 PUFA deprivation significantly decreased the binding of the nuclear proteins to the CREB consensus sequence by 31% (n = 10, P = 0.009) compared to the n-3 PUFA adequate rats (Figures 2c  and d) .
The decrease in CREB DNA-binding activity in n-3 PUFA deprived rats was associated with a decrease in the phosphorylated CREB protein level in nuclear Figure 1 Frontal cortex BDNF protein (a) and mRNA (b) levels in n-3 polyunsaturated fatty acid adequate (n-3 PUFA þ ) and n-3 polyunsaturated-deprived (n-3 PUFAÀ) rats. Data were compared using an unpaired t-test, mean7s.e.m., n = 10 independent samples for protein levels and n = 6 independent samples for mRNA levels, *P < 0.05. n-3 PUFA deprivation decreases BDNF levels JS Rao et al protein extracts (47%, n = 10, P = 0.02) (Figure 2e ) compared to the level in n-3 PUFA-adequate rats (n = 10). However, the CREB protein levels (n = 10) in cytosol and nuclear extracts were not significantly different in n-3 PUFA deprived rats compared to n-3 PUFA adequate rats (Figure 2f ).
Decreased p38 MAPK and nuclear phosphorylated p38 MAPK in n-3 PUFA deprived rats We examined protein kinases known to activate the CREB transcription factor in n-3 PUFA deprived and adequate rats. The kinases included PKA, [24] [25] [26] 27 p38, p42, p44 MAPK 28, 29 and CaMK IV. 30 N-3 PUFAdeprivation significantly increased (48%) basal PKA activity (n = 10, P = 0.037) (Figure 3a ) but did not significantly change CaMK IV activity (Figure 3b ), basal PKC kinase activity (Figure 3c ), p44 MAPK activity (Figure 3d ) or nuclear phosphorylated p42 and p44 MAPK levels (Figure 3e ) compared to n-3-adequate rats. Cytosolic p38 MAPK activity and nuclear phosphorylated p38 MAPK protein levels were decreased by 34% (n = 10, P = 0.04) and 32% (n = 10, P = 0.01) respectively, compared to levels in n-3 PUFA adequate rats (Figures 4a and b) .
BDNF protein level is increased by DHA but blocked by p38 MAPK inhibitor in rat primary astrocytes Rat primary cortical astrocytes exhibited positive staining to GFAP antibody and DAPI stain under all treatment conditions, as represented in Figure 5 . The incubation of astrocytes in the presence of 1.5 mM DHA significantly increased the BDNF protein level in their cellular extracts (Figure 6a) . To see if this increase depended on p38 MAPK activity, we also added a p38 MAPK inhibitor to the medium (20 mM SB202190), and this significantly reduced BDNF Figure 2 Representative gelshifts of CREB DNA-binding activity in rat frontal cortex of n-3 PUFA þ and PUFAÀ rats. Specificity of CREB DNA-protein binding activity was tested in nuclear extracts in the presence of CREB antibody and excess cold CREB oligonucleotides. The CREB antibody generated a supershift (a) and in the presence of excess amount of unlabeled CREB oligonucleotides (100 times) blocked the binding of labeled probe (b). Representative CREB DNA-binding activity in the frontal cortex of n-3 PUFA þ and n-3 PUFAÀ rats (c). CREB DNA-binding activity in n-3 PUFA þ and n-3 PUFAÀ rats (d). Representative nuclear immunoblots and protein levels of phosphorylated CREB from n-3 PUFA þ and n-3 PUFAÀ rats (e). Representative cytosol and nuclear immunoblots and protein levels of CREB from n-3 PUFA þ and n-3 PUFAÀ rats (f). Data were compared using an unpaired t-test, mean7s.e.m., n = 10 independent samples per group, *P < 0.05, **P < 0.001. n-3 PUFA deprivation decreases BDNF levels JS Rao et al protein compared to the DHA supplemented cells (Figure 6a) . The BDNF protein level in the presence of DHA and 20 mM SB202190 was lower than in the absence of DHA, suggesting that PKA also was inhibited by DHA. We confirmed this by showing that 1.5 mM DHA inhibited PKA activity in the absence and presence of the p38 MAPK inhibitor (Figure 6b ). The addition 1.5 mM DHA induced p38 MAPK activity, which was blocked by the addition of 20 mM SB202190 (Figure 6c ).
Discussion
The present study in rats following weaning demonstrates that 15 weeks of n-3 PUFA-deprivation reduced the DHA concentration in the frontal cortex by 27% and caused changes in cellular signaling cascades. The reduction in frontal cortex DHA was comparable to reductions of 16.5 and 28% reported in the prefrontal cortex of bipolar and major depressive disorder patients, respectively. 12 N-3 PUFA-deprivation also decreased phosphorylated p38 MAPK activity, CREB DNA-binding activity and BDNF mRNA and protein in the frontal cortex. Supplementation of primary rat cortical astrocytes with 1.5 mM DHA induced BDNF protein expression which could be blocked by adding a p38 MAPK inhibitor to the medium. One or a combination of these factors could contribute to increased depression and aggression scores reported in response to n-3 PUFA deprivation in rats. 15, 39, [59] [60] [61] [62] As CREB has been implicated in the pathophysiology of depression as well as of bipolar disorder, 33, 63, 64 n-3 PUFAs' ability to regulate CREB could be related to their effects in these diseases.
CREB requires phosphorylation in order to transcribe CREB-regulated genes, including BDNF. 23 Thus, decreased CREB DNA activity may be responsible for the decreased expression of BDNF mRNA in n-3 PUFA-deprived rats. PKA, [24] [25] [26] PKC, 27 MAPK 28 and CaMK IV 30 are known to phosphorylate the Ser-133 residue of the CREB transcription factor, and thereby enhance its binding to the CRE consensus in the nucleus, leading to increased transcription. Exogenous DHA decreases cytosolic and particulate PKA activity in macrophage tumor cells (AK-5) 65 and decreases catalytic PKA activity in vitro. 66 In the current study, n-3 PUFA deprivation significantly increased basal PKA activity in the frontal cortex due to a loss of the inhibitory effect of DHA possibly. We also observed that the addition of DHA to rat primary cortical astrocytes decreased PKA activity. Lymphoblast and platelets isolated from bipolar disorder patients have increased cAMP-dependent PKA activity, [67] [68] [69] and basal and cAMP-dependent Representative frontal cortex nuclear immunoblots of phosphorylated MAPK p42 and p44 protein levels in n-3 PUFA þ and n-3 PUFAÀ rats (e). Data were compared using unpaired t-tests, mean7s.e.m., n = 10 independent samples per group, *P < 0.05.
n-3 PUFA deprivation decreases BDNF levels JS Rao et al PKA activities are increased in post-mortem brains of bipolar disorder patients. 70, 71 Chronic administration of the mood stabilizer carbamazepine to rats decreased frontal cortex cAMP-dependent PKA activity. 72 The observation that n-3 PUFA deprived rats had increased brain PKA activity suggests that another kinase downregulated CREB phosphorylation and a greater extent than the increased PKA activity could phosphorylate CREB. This observation is similar to a study in which fluoxetine increased the phosphorylation of CREB by a MAPK but not a PKAdependent mechanism. 30 PKC can phosphorylate CREB and is implicated in the pathogenesis of bipolar disorder. 73 Subtypes of PKC are classified based on their distribution and calcium requirement. DHA increases PKC activity in macrophage cell lines, 65 but inhibits activity of isolated catalytic PKC subunits. 66 In the present study, there was no significant difference in total PKC activity, but an effect on PKC isoforms cannot be ruled out.
MAPKs are serine-threonine kinases that can phosphorylate CREB and that have been implicated in the pathophysiology of affective disorder and major depression. 74, 75 They comprise four subfamilies: (1) extracellular signal-regulated kinases (ERK1/2 also referred to as p42 and p44 MAPK, respectively), (2) c-Jun N-terminal kinases (JNK), (3) ERK5/big MAPK 1 (BMK1) and (4) p38 MAPK. p38 and p44 MAPK are activated by phosphorylation of serine and tyrosine residues and are translocated into the nucleus where they can phosphorylate several transcription factors, including CREB. 76, 77 n-3 PUFA deprivation decreased basal cytosolic p38 MAPK activity and nuclear phosphorylated p38 MAPK protein without altering basal cytosolic p44 MAPK activity or nuclear phosphorylated p42 or p44 MAPK protein. Thus, the decreased basal p38 MAPK activity may be responsible for the decreased phosphorylation of CREB, which could be responsible for the decreased CREB DNA-binding activity and ultimately for the reduced transcription and translation of BDNF in the frontal cortex of n-3 PUFAdeprived rats. In support of this, addition of a p38 MAPK inhibitor to rat astrocytes decreased BDNF protein, even in the low DHA groups where PKA activity was increased.
The BDNF/MAPK pathway is thought to regulate affective-like behaviors in rodents. 38, 78 Selective conditional BDNF knockout mice are reported to have depression-related behaviors. 79 Together, these reports support a neurotrophic hypothesis for depression. The current study indicates that decreased p38 MAPK activity is involved in functional changes observed in n-3 PUFA deprived rats. 15 Fluoxetine also activates the p38 MAPK cascade, 80 suggesting that the depressive symptoms observed in n-3 PUFA deprived rats are related to decreased p38 MAPK activity. Constitutive p38 MAPK activity maintains the expression of rat brain dopamine 81, 82 and serotonin transporters 83 and n-3 PUFA deprivation upregulates D1 and D2 receptors 84 and decreases stimulated serotonin release, 85 all of which are believed to be involved in depression.
Fifteen weeks of n-3 PUFA-deprivation decreased frontal cortex DHA, BDNF, phosphorylated CREB and p38 MAPK levels. DHA's ability to induce BDNF in Figure 4 Frontal cortex cytosolic p38 MAPK activity in n-3 PUFA þ and n-3 PUFAÀ rats (a). Phosphorylated p38 MAPK protein levels in n-3 PUFA þ and n-3 PUFAÀ rats (b). Data were compared using unpaired t-tests, mean7 s.e.m., n = 10 independent samples per group, *P < 0.05. Figure 5 Representative rat cortical astrocytes with glial, fibrillary acidic protein and DAPI staining.
n-3 PUFA deprivation decreases BDNF levels JS Rao et al rat primary cortical astrocytes was blocked by a p38 MAPK inhibitor. Some of these changes overlap with changes in the postmortem brain of bipolar patients (increased PKA activity, decreased phosphorylated CREB and BDNF protein levels). Decreased BDNF may lower neuronal and glial cell number as observed in the brain of bipolar patients, 47 and BDNF knockdown/knockout mice have increased depressive behavioral scores. 63, 79 More studies are required to elucidate the role of BDNF in bipolar disorder. As n-3 PUFA and BDNF have been implicated in the pathogenesis of bipolar disorder, this may be how n-3 PUFAs exert their effects in the disorder. Along with studies demonstrating DHA to be neuroprotective by increasing Atk 86 and syntaxin 3 87 signaling while decreasing proinflammatory gene expression, 88, 89 oxidative stress, markers of synaptic loss, and behavioral defects in a mouse model of Alzheimer's disease, 90 the finding that dietary n-3 PUFAs can influence frontal cortex p38 MAPK, CREB and BDNF has implications for the role of n-3 PUFAs in a number of brain diseases.
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